CryoPort (CYRX) Competitors $8.64 -0.83 (-8.76%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$8.64 0.00 (0.00%) As of 09/12/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. HRMY, ANIP, ARQT, DYN, RXRX, ADPT, TVTX, IMCR, MESO, and SRPTShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Harmony Biosciences (HRMY), ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Dyne Therapeutics (DYN), Recursion Pharmaceuticals (RXRX), Adaptive Biotechnologies (ADPT), Travere Therapeutics (TVTX), Immunocore (IMCR), Mesoblast (MESO), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Harmony Biosciences ANI Pharmaceuticals Arcutis Biotherapeutics Dyne Therapeutics Recursion Pharmaceuticals Adaptive Biotechnologies Travere Therapeutics Immunocore Mesoblast Sarepta Therapeutics CryoPort (NASDAQ:CYRX) and Harmony Biosciences (NASDAQ:HRMY) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts recommend CYRX or HRMY? CryoPort currently has a consensus target price of $12.00, indicating a potential upside of 38.89%. Harmony Biosciences has a consensus target price of $51.00, indicating a potential upside of 57.46%. Given Harmony Biosciences' higher probable upside, analysts plainly believe Harmony Biosciences is more favorable than CryoPort.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CryoPort 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Harmony Biosciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, CYRX or HRMY? CryoPort has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Harmony Biosciences has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Is CYRX or HRMY more profitable? CryoPort has a net margin of 37.21% compared to Harmony Biosciences' net margin of 23.44%. Harmony Biosciences' return on equity of 26.34% beat CryoPort's return on equity.Company Net Margins Return on Equity Return on Assets CryoPort37.21% -9.79% -5.42% Harmony Biosciences 23.44%26.34%17.71% Do insiders and institutionals hold more shares of CYRX or HRMY? 92.9% of CryoPort shares are held by institutional investors. Comparatively, 86.2% of Harmony Biosciences shares are held by institutional investors. 10.0% of CryoPort shares are held by company insiders. Comparatively, 23.6% of Harmony Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer CYRX or HRMY? In the previous week, Harmony Biosciences had 1 more articles in the media than CryoPort. MarketBeat recorded 8 mentions for Harmony Biosciences and 7 mentions for CryoPort. Harmony Biosciences' average media sentiment score of 1.52 beat CryoPort's score of 1.31 indicating that Harmony Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CryoPort 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Harmony Biosciences 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation and earnings, CYRX or HRMY? Harmony Biosciences has higher revenue and earnings than CryoPort. CryoPort is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoPort$228.38M1.89-$114.76M$1.336.50Harmony Biosciences$772.53M2.41$145.49M$3.1010.45 SummaryHarmony Biosciences beats CryoPort on 11 of the 14 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$474.13M$5.67B$7.07B$10.14BDividend YieldN/A2.35%940.00%4.60%P/E Ratio6.5010.9613.7125.98Price / Sales1.890.76637.55180.60Price / CashN/A11.238.0260.44Price / Book1.163.072.206.29Net Income-$114.76M$184.49M$556.72M$271.07M7 Day Performance-16.52%2.64%1.09%3.87%1 Month Performance-2.37%3.05%2.67%5.49%1 Year Performance3.47%-1.59%11.32%25.86% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort3.7399 of 5 stars$8.64-8.8%$12.00+38.9%+3.5%$474.13M$228.38M6.501,186News CoveragePositive NewsInsider TradeHigh Trading VolumeHRMYHarmony Biosciences4.6066 of 5 stars$35.83-0.4%$51.00+42.3%-16.8%$2.07B$714.73M11.56200Positive NewsHigh Trading VolumeANIPANI Pharmaceuticals3.9375 of 5 stars$95.20-0.2%$88.25-7.3%+67.0%$2.07B$614.38M-123.63600ARQTArcutis Biotherapeutics2.201 of 5 stars$17.33+1.0%$19.80+14.3%+62.2%$2.06B$196.54M-23.11150News CoverageInsider TradeDYNDyne Therapeutics3.7914 of 5 stars$13.30-6.5%$34.07+156.1%-61.4%$2.02BN/A-3.45100Positive NewsRXRXRecursion Pharmaceuticals2.1606 of 5 stars$4.62+0.2%$7.25+56.9%-26.5%$2.00B$58.84M-2.60400News CoverageAnalyst ForecastOptions VolumeGap UpADPTAdaptive Biotechnologies3.6551 of 5 stars$12.54-2.4%$12.38-1.3%+173.5%$1.96B$178.96M-15.29790Positive NewsTVTXTravere Therapeutics2.9782 of 5 stars$21.20-2.0%$33.43+57.7%+74.1%$1.93B$233.18M-10.39460News CoveragePositive NewsAnalyst ForecastIMCRImmunocore2.0432 of 5 stars$36.64-1.5%$56.89+55.3%+5.0%$1.87B$310.20M-91.60320Positive NewsMESOMesoblast2.0504 of 5 stars$14.55+1.1%$18.00+23.7%+138.3%$1.84B$17.20M0.0080Positive NewsGap DownSRPTSarepta Therapeutics4.4333 of 5 stars$17.60-5.9%$43.50+147.2%-86.0%$1.83B$1.90B-20.231,372Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Harmony Biosciences Competitors ANI Pharmaceuticals Competitors Arcutis Biotherapeutics Competitors Dyne Therapeutics Competitors Recursion Pharmaceuticals Competitors Adaptive Biotechnologies Competitors Travere Therapeutics Competitors Immunocore Competitors Mesoblast Competitors Sarepta Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts